This announcement is a separate document:
佐力药业：关于公司高级管理人员收到浙江证监局监管谈话措施决定的公告
Zhejiang Jolly Pharmaceutical: Notice on the company's senior management receiving the Zhejiang Securities Regulatory Bureau's regulatory dialogue measures decision
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.